Ketamine Providers in Maryland
17 providers across 10 cities
Maryland has 17 ketamine therapy providers across 10 cities. The most common provider types are psychiatry practice, ketamine infusion clinic, wellness & integrative center. Providers in Maryland commonly treat depression, anxiety, ptsd. Top cities include Bethesda, Annapolis, Baltimore, Columbia, Frederick.
Ketamine Therapy in Maryland
Maryland offers some of the most accessible ketamine therapy in the mid-Atlantic region, with established clinics in Baltimore, Bethesda, Columbia, and the greater DC corridor. The state has a functioning Medicaid prior authorization pathway for Spravato, and select providers hold VA partnership status allowing eligible veterans to receive treatment at no cost. Maryland's proximity to major research institutions, including Johns Hopkins, has kept it at the forefront of psychiatric innovation.
Maryland ranks 17th nationally with 17 ketamine therapy providers, averaging 1.7 providers per city. The largest provider category is psychiatry practice (35.3% of providers). Bethesda leads the state with 4 providers.
State Regulations
Maryland follows federal Schedule III regulations for ketamine without additional state-specific clinic legislation. Maryland enacted Senate Bill 78 (2021) requiring annual reporting on ketamine use by EMS personnel through 2024, reflecting the state's attention to ketamine administration at all care levels. The Maryland Board of Physicians oversees practitioners under standard controlled substance rules.
Insurance & Medicaid Coverage
Maryland Medicaid (MMCP) covers Spravato with a dedicated prior authorization form managed by the Maryland Department of Health Office of Pharmacy Services. Requirements include TRD diagnosis, failure of at least two different preferred oral antidepressants at adequate dosage for at least 42 days each, and psychiatrist prescription. Induction approval is 4 weeks; maintenance is 6 months.
Telehealth Options
Maryland permits telemedicine prescribing of ketamine under the DEA's extension through December 31, 2026. Maryland has no additional state restrictions on telehealth prescribing of Schedule III substances beyond federal DEA requirements.
Cost of Ketamine Therapy
IV ketamine infusions in Maryland typically cost $400–$1000 per session. Baltimore clinics charge $450-$750 per IV infusion for mental health. Bethesda/DMV market follows similar pricing. Pain protocols run significantly higher ($850-$1,500). A standard initial series of 6 infusions runs $2400–$6000. Spravato (esketamine) may be partially or fully covered by insurance.
Mental Health Access
Maryland has only 22.10% of mental health needs met, requiring 81 additional practitioners (HRSA, December 2025). Despite proximity to Washington D.C. and major academic medical centers, many Maryland communities — particularly rural areas in Western Maryland and the Eastern Shore — face significant mental health provider shortages. Maryland has approximately 0.31 ketamine providers per 100,000 residents.
Frequently Asked Questions
- Yes. Ketamine is a Schedule III controlled substance legal for off-label therapeutic use when administered by licensed medical professionals with valid DEA registration. Maryland clinics offer IV ketamine infusions, IM injections, and FDA-approved Spravato. No separate clinic registration is required beyond standard business licensing and DEA registration.
- Yes. Maryland Medicaid covers Spravato with prior authorization administered through the Maryland Department of Health Office of Pharmacy Services. Patients must have a TRD diagnosis, demonstrate failure of at least two adequate antidepressant trials, and receive a prescription from a psychiatrist. Veterans may be eligible for free ketamine through VA-approved Maryland providers.
- IV ketamine infusions in Maryland typically range from $400-$1,000 per session, with the Baltimore and Bethesda markets generally in the $450-$750 range for mental health indications. A standard 6-session protocol costs approximately $2,400-$6,000.